Julio Rifá, MD

home / authors / julio-rifá-md

Articles

Site Logo

UFT Plus or Minus Calcium Folinate for Metastatic Colorectal Cancer in Older Patients

Eduardo Diaz-rubio, MD, PhD;Javier Sastre, MD, PhD;Albert Abad, MD, PhD;Matilde Navarro, MD;Enrique Aranda, MD, PhD;Alfredo Carrato, MD, PhD;Manuel Gallén, MD;Eugenio Marcuello, MD;Julio Rifá, MD;Tomeu Massuti, MD;Andrés Cervantes, MD, PhD;Antonio Antón, MD, PhD;Carlos Fernandez-martos, MD
July 1st 1999

Two studies were carried out to determine the activity and evaluate the toxicity of oral chemotherapy with uracil and tegafur in a 4:1 molar ratio (UFT) plus or minus calcium folinate in elderly patients with advanced colorectal

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
The Hidden Danger Unveiling the Connection Between Multiple Myeloma and Pleural Effusion
Published: November 8th 2024 | Updated: November 21st 2024
The Hidden Danger Unveiling the Connection Between Multiple Myeloma and Pleural Effusion
Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship
Published: November 7th 2024 | Updated: November 21st 2024
Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?
Published: November 12th 2024 | Updated: November 21st 2024
Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?